Sign in

CIK 0001527728 · Non-accelerated filer<br>Smaller reporting company

Lunai Bioworks Inc.

Sign in to watch
Ticker
LNAI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
452259340
Phone
45 39179840
Business address
CENTURY CITY MEDICAL PLAZA, 2080 CENTURY CITY EAST, SUITE 906 LOS ANGELES, CA, 90067
Former names
RENOVARO INC., RENOVARO BIOSCIENCES INC., Enochian Biosciences Inc, DanDrit Biotech USA, Inc., Putnam Hills Corp.
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy Director bought 31,500 shares at $6.70 ($211,050)
  3. 4/A Open-market buy Director bought 36,200 shares at $6.61 ($239,282)
  4. 4 Open-market buy Director bought 40,000 shares at $6.70 ($268,000)
  5. 4 Open-market buy Director bought 20,000 shares at $6.60 ($132,000)
  6. 4 Open-market buy Director bought 5,014 shares at $6.25 ($31,338)
  7. 4 Open-market buy Director bought 36,200 shares at $6.61 ($239,282)
  8. 4 Open-market buy Director bought 500 shares at $5.76 ($2,880)
  9. 4 Open-market buy Director bought 20,000 shares at $5.75 ($115,000)
  10. 10-Q Report Quarterly Report
  11. NT 10-Q Other NT 10-Q
  12. 8-K Event Regulation FD disclosure
  13. 8-K Event Regulation FD disclosure
  14. 8-K Event Regulation FD disclosure
  15. 3 Insider Initial Statement of Ownership
  16. 10-Q Report Quarterly Report
  17. 8-K Event Regulation FD disclosure
  18. 4 Open-market buy Director bought 50,000 shares at $2.00 ($100,000)
  19. 8-K Event Executive or director change
  20. 8-K Event Executive or director change · Bylaws or fiscal year change · Other events

Page 22 of 31 · 601 filings